Search

Your search keyword '"Arakawa Hiroshi"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Arakawa Hiroshi" Remove constraint Author: "Arakawa Hiroshi" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
138 results on '"Arakawa Hiroshi"'

Search Results

1. ODA: Observation-Driven Agent for integrating LLMs and Knowledge Graphs

11. Cytochrome P450 and UDP-glucuronosyltransferase expressions, activities, and induction abilities in 3D-cultured human renal proximal tubule epithelial cells

13. The Natural Evolution of RNA Viruses Provides Important Clues about the Origin of SARS-CoV-2 Variants.

15. Prediction and causal inference of hyperuricemia using gut microbiota

18. Dynamic, IPSC-derived hepatic tissue tri-culture system for the evaluation of liver physiology in vitro

19. A Supramolecular Biosensor for Rapid and High-Throughput Quantification of a Disease-Associated Niacin Metabolite

20. Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study.

22. Gut–liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism

23. Drug–drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers

26. A highly efficient cell culture method using oxygen‐permeable PDMS‐based honeycomb microwells produces functional liver organoids from human induced pluripotent stem cell‐derived carboxypeptidase M liver progenitor cells

28. Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer

29. Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system

33. Improvement of Protein Expression Profile in Three-Dimensional Renal Proximal Tubular Epithelial Cell Spheroids Selected Based on OAT1 Gene Expression: A Potential In Vitro Tool for Evaluating Human Renal Proximal Tubular Toxicity and Drug Disposition

35. Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer

36. Supplementary Figure S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer

37. Supplementary Table S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer

38. Supplementary Data from Multiple Repair Pathways Mediate Tolerance to Chemotherapeutic Cross-linking Agents in Vertebrate Cells

39. Supplementary Figure 1 from Cells Deficient in the FANC/BRCA Pathway Are Hypersensitive to Plasma Levels of Formaldehyde

40. Data from Cells Deficient in the FANC/BRCA Pathway Are Hypersensitive to Plasma Levels of Formaldehyde

46. Mutation signature of SARS-CoV-2 variants raises questions to their natural origins

47. Influence of CPM-dependent sorting on the multi-omics profile of hepatocyte-like cells matured in microscale biochips

Catalog

Books, media, physical & digital resources